Companies

REPLIGEN CORP (RGEN) SEC filings

CIK 0000730272 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2017FY2016
Revenue (USD)141.2 M63.5 M
Net income (USD)48.9 M186.0 M
Diluted EPS (USD/shares)0.863.24

Latest filings

FiledFormDescriptionPeriod
2026-10-084FORM 42026-10-06
2026-10-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-064FORM 42026-10-05
2026-10-068-K8-K items 2.01,7.01,9.012026-10-06
2026-10-05144144
2026-10-054FORM 42026-10-02
2026-10-05144144
2026-09-30425425
2026-09-284FORM 42026-09-25
2026-09-254FORM 42026-09-24
2026-09-24144144
2026-09-224FORM 42026-09-21
2026-09-21144144
2026-09-158-K8-K items 5.022026-09-10
2026-09-08425425
2026-09-088-K8-K items 8.012026-09-03
2026-09-084FORM 42026-09-03
2026-09-04EFFECTEFFECT items ,,
2026-09-04424B3424B3
2026-09-04144144
2026-09-04S-4/AS-4/A
2026-09-024FORM 42026-03-05
2026-08-25S-4S-4
2026-08-214FORM 42026-08-20
2026-08-20144144

Forms on file (last 1,000): 4 496, 8-K 166, 10-Q 49, SC 13G/A 46, 144 29, 3 23, DEF 14A 17, 10-K 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RGEN (0.002 USD), /gw/filings/filings?ticker=RGEN&form=8-K, /gw/filings/facts?ticker=RGEN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange